ArticleCancers2026

Efficacy and Safety of CAR-T Cell Therapy and Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma with Renal Impairment: A Propensity Score-Matched Analysis.

Anushareddy Muddasani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.